(Q51378818)

4 April 2018

title

Long-lasting remission of type 1 diabetes following treatment with topiramate for generalized seizures. (English)

1 reference

4 April 2018

0 references

2

1 reference

4 April 2018

Franco Folli

object named as

Franco B Folli

series ordinal

3

0 references

author name string

Alberto M Davalli

series ordinal

1

1 reference

4 April 2018

Emanuele Bosi

series ordinal

4

1 reference

4 April 2018

publication date

19 February 2011

1 reference

4 April 2018

published in

Acta Diabetologica

1 reference

4 April 2018

volume

49

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

75-79

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s00592-011-0268-y

exact match

0 references

cites work

The honeymoon phase: intersection of metabolism and immunology

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

The antiepileptic drug topiramate preserves metabolism-secretion coupling in insulin secreting cells chronically exposed to the fatty acid oleate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

The activity of antiepileptic drugs as histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

Role of histone and transcription factor acetylation in diabetes pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

Deacetylase inhibition promotes the generation and function of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

Immunotherapy of type 1 diabetes: where are we and where should we be going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0268-Y

10.1007/S00592-011-0268-Y

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018